Research Lab Review

MOTS-c and the aging ovary: what new lab studies do and don’t show

News · MOTS-c

A cell and mouse-oocyte study and two reviews look at MOTS-c and energy use in aging ovarian cells. The human evidence is still a single unreplicated finding.

A new laboratory study reports that MOTS-c, a small peptide encoded in mitochondrial DNA, changed how aging-model ovarian support cells produce energy, and was linked to better maturation in eggs from older mice [1]. Two recent reviews place this work in a wider picture of mitochondrial-derived peptides in reproduction and metabolism [2, 3]. The results are early and come from cells and mice, so the useful question is what they actually measured and what is still missing in people.

Key takeaways

  • In a human granulosa cell line used as an aging model, adding MOTS-c was associated with more mitochondria and higher ATP-linked and maximal respiration, without a rise in reactive oxygen species [1].
  • In eggs from aged mice cultured outside the body, MOTS-c exposure was linked to more first polar body extrusion (a sign of maturation) and lower oxidative-stress signals, but results stayed below those of young mice [1].
  • The study did not test fertilization, embryo development or live birth, and it included no women [1].
  • The only human clinical link cited is lower blood MOTS-c in polycystic ovary syndrome, a finding the review’s authors describe as unreplicated and without ovarian sampling [2].

Molecular model of mitochondrial ATP synthase with the alpha subunit highlighted in green

Why mitochondria matter for egg quality

Eggs develop surrounded by granulosa cells, which supply them with energy and signals as they mature [1]. Ovarian aging is associated with poorer granulosa cell function, disturbed mitochondrial balance and declining oocyte quality [1].

MOTS-c belongs to a group called mitochondrial-derived peptides, along with humanin and small humanin-like peptide 2 (SHLP2), which are encoded in the mitochondrial genome and are involved in metabolism, oxidative stress and cell death [2]. According to a recent review, levels of all three decline with age in humans, which parallels the age-related decline in egg quality [2]. A parallel trend is not the same as cause and effect, which is part of why the new lab work was done.

The new study: cells and mouse eggs

What kind of study. This was a laboratory study published in Reproduction and Fertility combining three approaches: a human granulosa cell line (HGL5) set up as an aging-associated model, eggs from young and aged mice studied ex vivo (outside the body), and reanalysis of public gene-expression datasets [1]. The abstract does not report how many mice or eggs were used.

Granulosa cell findings. In the HGL5 cells, MOTS-c increased mitochondrial mass and ATP-associated fluorescence, without increasing cellular or mitochondrial reactive oxygen species [1]. Membrane potential, once adjusted for mitochondrial mass, did not change [1]. Using Seahorse respiration analysis, the authors saw higher ATP-linked respiration, higher maximal respiration and more spare respiratory capacity, with less proton leak and no change in baseline respiration [1].

In plain terms, the cells did not burn more fuel at rest, but appeared to have more reserve capacity and wasted less energy as leak [1]. MOTS-c also shifted the levels of enzymes involved in glycolysis, lactate and pyruvate handling, and the entry of pyruvate into the TCA cycle [1].

The researchers reported higher levels of several proteins linked to antioxidant defense (NRF2), mitochondrial transport (RHOT1, KIF5B), cell junctions (ZO-1, E-cadherin), adhesion signaling (phosphorylated FAK) and granulosa cell function (AMH) [1]. Markers of mitochondrial fission were largely unchanged [1].

Mouse egg findings. Eggs from aged mice showed lower polar body extrusion, higher DCFDA fluorescence (an oxidative-stress indicator) and lower CMXRos intensity (a mitochondrial stain) than eggs from young mice [1]. After ex vivo exposure to MOTS-c, aged eggs showed more first polar body positivity after culture, more mitochondria-associated fluorescence and less oxidative-stress-associated fluorescence [1]. These measures still did not reach young-mouse reference levels [1].

Dataset reanalysis. Looking at existing data on human follicle development and ovarian aging in nonhuman primates, the authors reported a trend toward a MOTS-c-associated metabolic program being more active in younger samples [1]. This is a pattern in gene expression, not a measurement of MOTS-c itself or of its effects.

Limits. The authors themselves state that the results come from laboratory and animal experiments, not women, and that fertilization, embryo development and live birth were not tested [1]. A single cell line may not behave like granulosa cells in a living ovary. Polar body extrusion and fluorescence readouts are markers of maturation and cell state, not measures of whether an egg can produce a healthy pregnancy. Mouse results do not show what would happen in people.

Review 1: a hypothesis-driven perspective on fertility

What kind of study. A review in Tissue and Cell describes itself as a hypothesis-driven perspective [2]. The authors searched PubMed, Scopus and Web of Science up to May 2025, found 312 records and kept 87 [2]. Its stated aims were to build a mechanistic framework from indirect evidence, propose research priorities and outline possible routes toward biomarkers in assisted reproduction [2].

What it says. The review summarizes proposed mechanisms: MOTS-c activates the energy sensor AMPK, humanin binds the pro-apoptotic protein Bax, and SHLP2 reduces mitochondrial reactive oxygen species while increasing electron transport chain activity [2]. It notes that humanin has been detected in human follicular fluid and is associated with ovarian reserve and insulin resistance in polycystic ovary syndrome [2]. The review uses the newer name polyendocrine metabolic ovarian syndrome (PMOS) for this condition [2].

The authors propose, but have not shown, that MOTS-c and SHLP2 will also be found in follicular fluid, and that a combined panel of these peptides might predict IVF outcomes better than AMH alone [2].

The human finding. The one direct clinical data point for MOTS-c is a reported 56% lower serum concentration in PCOS compared with controls (P < 0.001) [2]. The review’s authors call this preliminary, unreplicated and lacking ovarian sampling [2]. A blood level does not tell us what is happening inside the ovary, and a single study cannot show whether low MOTS-c is a cause, a consequence or unrelated to the condition.

Limits. By design, this review builds hypotheses from indirect evidence rather than testing them [2]. Its own conclusion is that direct testing, starting with measuring these peptides in human follicular fluid and granulosa cells, is now needed [2].

Review 2: a wider metabolic context

A separate review in Cells focuses on pancreatic beta cells in type 2 diabetes, and on the contact points between mitochondria and the endoplasmic reticulum that help coordinate calcium handling and ATP production [3]. It describes how metabolic and inflammatory stress can push these contacts toward calcium overload, reactive oxygen species build-up, senescence and cell death [3].

The review lists MOTS-c among approaches under study for their effects at this interface, alongside incretin-based agents [3]. It is relevant here mainly as background: it shows that interest in MOTS-c centers on mitochondrial energy handling across tissues, not only the ovary. The authors also note that rodent and human data diverge on the composition of these contact sites and on responses to high glucose [3], a reminder that animal findings in this area do not transfer directly to people.

What we still don’t know

  • Whether any of this happens in women. No study among these sources measured MOTS-c in human ovaries, follicular fluid or eggs [1, 2].
  • Whether maturation markers mean better outcomes. The new study did not test fertilization, embryo development or live birth [1].
  • Whether the PCOS finding holds up. The lower serum MOTS-c result has not been replicated and did not include ovarian sampling [2].
  • How MOTS-c acts in a whole organism. Results came from a cell line and from eggs cultured outside the body, which may not reflect conditions in a living ovary [1].
  • Safety and effects in people. None of the sources report human data on giving MOTS-c in a reproductive setting [1, 2, 3].

For now, the evidence supports further laboratory and observational research, and does not support conclusions about fertility in people [1, 2].

References

  1. The mitochondrial-derived peptide MOTS-c improves bioenergetics in aging-associated granulosa cells and oocytes. Reproduction and Fertility (2026). doi:10.1530/RAF-26-0161
  2. Mitochondrial-derived peptides in female reproduction: Emerging regulators of oocyte competence and novel therapeutic opportunities for infertility. Tissue and Cell (2027). doi:10.1016/j.tice.2026.104044
  3. Mitochondria–Endoplasmic Reticulum Crosstalk in Pancreatic β-Cell Stress: A Driver of Diabetes. Cells (2026). doi:10.3390/cells15191733

Image credits

Free to use (CC0 / public domain); credited as a courtesy.

  • Ovarian granulosa cell clusters in an 18-year-old squirrel monkey.jpg, by Tulemo (CC0, via wikimedia-commons): source
  • ATP5A1 within ATP synthase – 1BMF.png, by Abrahams JP, Leslie AG, Lutter R, Walker JE (CC0, via wikimedia-commons): source